Paradigm has raised $1.2 billion for a new venture fund, giving one of crypto's most prominent investment firms fresh capital as it expands into artificial intelligence, robotics and other frontier ...

Crypto VC firm Paradigm has raised $1.2 billion — its third venture fund and fourth overall — with the aim of investing in the “technical frontier,” the firm’s founder Matt Huang announced Wednesday.

Paradigm is a Canadian (Toronto-based) hi-fi manufacturer that has been making high-performance loudspeakers since the early ’80s. In 2018, the company introduced the Premier Series, an affordable ...

Gil Harari and Jonathan Silverman have rejoined Paradigm to lead a new Physical Production department, marking a full-circle moment for the pair, amid the agency’s expansion in below-the-line ...

Following the most recent Teenage Mutant Ninja Turtles release, the next Magic: The Gathering set returns to one of its own beloved worlds. Secrets of Strixhaven brings players back to the magical ...

Photo: Edgar Bernard, Inmaculada Fortanet, Noelia Ruiz i Julia Valeiras. The Research Group on Academic and Professional English at the Universitat Jaume I (GRAPE-UJI) is developing a computer tool to ...

Paradigm, one of the largest venture investors focused on crypto, is expanding its brief to include artificial intelligence, robotics and other forms of frontier-tech, according to people familiar ...

WALNUT CREEK, Calif.--(BUSINESS WIRE)--Paradigm (“Paradigm” or the “Company”), a specialty care management organization focused on delivering solutions that improve outcomes for individuals with ...

If you’re traveling soon to a place where you don’t know the language well (or at all), then you’ll want to download a language learning app to your smartphone before you embark on your journey. These ...

Tech-enabled clinical research platform Paradigm Health has secured $78 million in an oversubscribed Series B financing round and announced its acquisition of oncology-focused digital health company ...

Matthew Herper covers medical innovation — both its promise and its perils. When people talk about using artificial intelligence to transform the way medicines are studied, they often imagine ...